Mammalian cystatin and protagonists in brain diseases

References

• Aatif, M., Rahman, S., & Bano, B. (2011). Protein unfolding studies of thiol-proteinase inhibitor from goat (Capra hircus) muscle in the presence of urea and GdnHCl as denaturants. European Biophysics Journal, 40(5), 611–617. doi:10.1007/s00249-010-0658-z
   PubMed Web of Science ®Google Scholar
• Abe, M., Abe, K., Kuroda, M., & Arai, S. (1992). Corn kernel cysteine proteinase inhibitor as a novel cystatin superfamily member of plant origin. Molecular cloning and expression studies. European Journal of Biochemistry, 209(3), 933–937.
   PubMedGoogle Scholar
• Abrahamson, M., Barrett, A. J., Salvesen, G., & Grubb, A. (1986). Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. Journal of Biological Chemistry, 261, 11282–11289.
   PubMed Web of Science ®Google Scholar
• Abrahamson, M., Mason, R. W., Hansson, H., Buttle, D. J., Grubb, A., & Ohlsson, K. (1991). Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochemical Journal, 273(3), 621–626.
   PubMedGoogle Scholar
• Abrahamson, M., Olafsson, I., Palsdottir, A., Ulvsbäck, M., Lundwall, A., Jensson, O., & Grubb, A. (1990). Structure and expression of the human cystatin C gene. Biochemical Journal, 268(2), 287–294.
   PubMed Web of Science ®Google Scholar
• Agarwala, K. L., Kawabata, S., Hirata, M., Miyagi, M., Tsunasawa, S., & Iwanaga, S. (1996). A cysteine protease inhibitor stored in the large granules of horseshoe crab hemocytes: Purification, characterization, cDNA cloning and tissue localization. Journal of Biochemistry, 19(1), 85–94. doi:10.1093/oxfordjournals.jbchem.a021220
   Google Scholar
• Aghajanyan, H. G., Arzumanyan, A. M., Arutunyan, A. A., & Akopyan, T. N. (1988). Cystatins from bovine brain: Purification, some properties, and action on substance P degrading activity. Neurochemical Research, 13(8), 721–727. doi:10.1007/BF00971594
   PubMed Web of Science ®Google Scholar
• Aguirre, A., Testa-Weintraub, L. A., Banderas, J. A., Dunford, R., & Levine, M. J. (1992). Levels of salivary cystatins in periodontally healthy and diseased older adults. Archives of Oral Biology, 37(5), 355–361. doi:10.1016/0003-9969(92)90018-4
   PubMed Web of Science ®Google Scholar
• Aguzzi, A., Heikenwalder, M., & Polymenidou, M. (2007). Insights into prion strains and neurotoxicity. Nature Reviews Molecular Cell Biology, 8(7), 552–561. doi:10.1038/nrm2204
   PubMed Web of Science ®Google Scholar
• Aguzzi, A., Nuvolone, M., & Zhu, C. (2013). The immunobiology of prion diseases. Nature Reviews Immunology, 13(12), 888–902. PMID: 24189576 doi:10.1038/nri3553
   PubMed Web of Science ®Google Scholar
• Akman, B., Özdemir, F. N., Sezer, S., Miçozkadioglu, H., & Haberal, M. (2004). Depression levels before and after renal transplantation. Transplantation Proceedings, 36(1), 111–113. doi:10.1016/j.transproceed.2003.11.021
   PubMed Web of Science ®Google Scholar
• Alvarez-Fernandez, M., Liang, Y. H., Abrahamson, M., & Su, X. D. (2005). Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile. Journal of Biological Chemistry, 280(18), 18221–18228. doi:10.1074/jbc.M411914200
   PubMed Web of Science ®Google Scholar
• Alves, J. B., Alves, M. S. D., & Naito, Y. (1994). Induction of synthesis of the rat cystatin S protein by the submandibular gland during the acute phase of experimental chagas disease. Memórias Do Instituto Oswaldo Cruz, 89(1), 81–85. doi:10.1590/S0074-02761994000100014
   PubMed Web of Science ®Google Scholar
• Amin, F., & Bano, B. (2018). Spectroscopic Studies on free radical coalescing antioxidants and Brain protein cystatin. Journal of Biomolecular Structure and Dynamics, 25, 1–35. doi:10.1080/07391102.2018.1500946
   Google Scholar
• Amin, F., Bano, B. (2019). Putative involvement of thiol protease inhibitor in the function of alzheimer drug. Alzheimer’s Dementia and Korsakoff ’s Disease – Linking Memory Pathology, pp, 1–8. Doi: http://dx.doi.org/10.5772/intechopen.83578
   Google Scholar
• Amin, F., Khan, A., Rizvi, S. J., & Bano, B. (2011). Purification and characterization of buffalo brain cystatin. Protein & Peptide Letters, 18, 210–218. doi:10.2174/092986611794475011
   PubMed Web of Science ®Google Scholar
• Anastasi, A., Brown, M. A., Kembhavi, A. A., Nicklin, M. J., Sayers, C. A., Sunter, D. C., & Barrett, A. J. (1983). Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochemical Journal, 211(1), 129–138. doi:10.1042/bj2110129
   PubMed Web of Science ®Google Scholar
• Anderson, G. B., Choi, S. J., & Bondurant, R. H. (1994). Survival of porcine inner cell masses in culture and after injection into blastocysts. Theriogenology, 42(1), 204–212. doi:10.1016/0093-691X(94)90676-A
   PubMed Web of Science ®Google Scholar
• Ansari, R., Mahta, A., Mallack, E., & Luo, J. J. (2014). Hyperhomocysteinemia and neurologic disorders: A review. Journal of Clinical Neurology, 10(4), 281. doi:10.3988/jcn.2014.10.4.281
   PubMed Web of Science ®Google Scholar
• Arai, S., Matsumoto, I., Emori, Y., & Abe, K. (2002). Plant seed cystatins and their target enzymes of endogenous and exogenous origin. Journal of Agricultural and Food Chemistry, 50(22), 6612–6617. PMID: 12381160.
   PubMed Web of Science ®Google Scholar
• Babnik, J., Curin, V., Lah, T., Turk, V., & Skaleric, U. (1988). Cysteine proteinase inhibitors in inflamed human gingiva. Biological Chemistry Hoppe-Seyler, 369, 271–276.
   PubMed Web of Science ®Google Scholar
• Balbín, M., Hall, A., Grubb, A., Mason, R. W., López-Otín, C., & Abrahamson, M. (1994). Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases. Journal of Biological Chemistry, 269(37), 23156–23162.
   PubMed Web of Science ®Google Scholar
• Barja, G. (2004). Free radicals and aging. Trends in Neurosciences, 27(10), 595–600. doi:10.1016/j.tins.2004.07.005
   PubMed Web of Science ®Google Scholar
• Barka, T., Asbell, A., Noen, van der H., & Prasad, A. (1991). Cystatins in tear fluid. Current Eye Research, 10(1), 25–34.
   PubMed Web of Science ®Google Scholar
• Barker, R. A., & Williams-Gray, C. H. (2014). Mild cognitive impairment and Parkinson's disease–something to remember. Journal of Parkinson's Disease, 4(4), 651–656. doi:10.3233/JPD-140427Review.
   PubMedGoogle Scholar
• Barrett, A. J. (1987). The cystatins: A new class of peptidase inhibitors. Trends in Biochemical Sciences, 12, 193–196. doi:10.1016/0968-0004(87)90092-2
   Web of Science ®Google Scholar
• Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998). Handbook of proteolytic enzymes. San Diego, London: Academic Press.
   Google Scholar
• Barrett, A. J. (1981). Leukocyte elastase. Methods in Enzymology, 80 Pt C, 581–588.
   PubMed Web of Science ®Google Scholar
• Barrett, A. J., Davies, M. E., & Grubb, A. (1984). The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochemical and Biophysical Research Communications, 120(2), 631–636. doi:10.1016/0006-291X(84)91302-0
   PubMed Web of Science ®Google Scholar
• Barrett, A. J., Fritz, H., Grubb, A., Isemura, S., Järvinen, M., Katunuma, N., … Turk, V. (1986). Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochemical Journal, 236(1), 312.
   PubMed Web of Science ®Google Scholar
• Barrett, A. J., Rawlings, N. D., Davies, M. E., Machleidt, W., Salvesen, G., Turk, V., & Salvesen, G. (1986). Proteinase inhibitors (pp. 515–569). Amsterdam, Netherlands: Elsevier Science Publishers.
   Google Scholar
• Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60(1), 355–366. doi:10.1146/annurev.med.60.042307.110802
   PubMedGoogle Scholar
• Bertram, L., Hsiao, M., McQueen, M. B., Parkinson, M., Mullin, K., Blacker, D., & Tanzi, R. E. (2007). The LDLR locus in Alzheimer's disease: A family-based study and meta-analysis of case-control data. Neurobiology of Aging, 28(1), 18.
   PubMed Web of Science ®Google Scholar
• Bever, C. T., Jr., & Garver, D. W. (1995). Increased cathepsin B activity in multiple sclerosis brain. Journal of the Neurological Sciences, 131(1), 71–73. doi:10.1016/0022-510X(95)00039-5
   PubMed Web of Science ®Google Scholar
• Beyer, K., Lao, J. I., Gómez, M., Riutort, N., Latorre, P., Mate, J. L., & Ariza, A. (2001). Alzheimer’s disease and the cystatin C gene polymorphism: An association study. Neuroscience Letters, 315(1–2), 17–20.
   PubMed Web of Science ®Google Scholar
• Bige, L., Ouali, A., & Valin, C. (1985). Purification and characterization of a low molecular weight cysteine proteinase inhibitor from bovine muscle. Biochimica et Biophysica Acta, 843(3), 269–275. doi:10.1016/0304-4165(85)90148-5
   PubMedGoogle Scholar
• Björck, L., Grubb, A., & Kjellen, L. (1990). Cystatin C, a proteinase inhibitor, blocks replication of herpes simplex virus. Journal of Virology, 64, 385–386.
   Web of Science ®Google Scholar
• Bode, W., & Huber, R. (2000). Structural basis of the endoproteinase-protein inhibitor interaction. Biochimica et Biophysica Acta, 1477(1–2), 241–252. doi:10.1016/S0167-4838(99)00276-9
   PubMedGoogle Scholar
• Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., … Turk, V. (1988). The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. The EMBO Journal, 7(8), 2593–2599.
   PubMed Web of Science ®Google Scholar
• Bollengier, F. (1987). Cystatin C, alias post-^-globulin: A marker for multiple sclerosis. Journal of Clinical Chemistry and Biochemistry, 25(9), 589–593.
   PubMedGoogle Scholar
• Brosnan, J. T., Jacobs, R. L., Stead, L. M., & Brosnan, M. E. (2004). Methylation demand: A key determinant of homocysteine metabolism. Acta Biochimica Polonica, 51(2), 405–413.
   PubMed Web of Science ®Google Scholar
• Brzin, J., Kopitar, M., Locnikar, P., & Turk, V. (1982). An endogenous inhibitor of cysteine and serine proteinases from spleen. FEBS Letters, 138(2), 193–197.
   PubMed Web of Science ®Google Scholar
• Brzin, J., Kopitar, M., Turk, V., & Machleidt, W. (1983). Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 364(2), 1475–1480. doi:10.1515/bchm2.1983.364.2.1475
   PubMedGoogle Scholar
• Brzin, J., Popovic, T., & Turk, V. (1984). Human cystatin, a new protein inhibitor of cysteine proteinases. Biochemical and Biophysical Research Communications, 770, 103–109. doi:10.1016/0006-291X(84)91073-8
   Google Scholar
• Brzin, J., Popovic, T., Turk, V., Borchart, U., & Machleidt, W. (1984). Human cystatin, a new protein inhibitor of cysteine proteinases. Biochemical and Biophysical Research Communications, 118(1), 103–109. doi:10.1016/0006-291X(84)91073-8
   PubMed Web of Science ®Google Scholar
• Butler, E. A., & Flynn, F. V. (1961). The occurrence of post-gamma protein in urine: A new protein abnormality. Journal of Clinical Pathology, 14, 172–178. doi:10.1136/jcp.14.2.172
   PubMed Web of Science ®Google Scholar
• Buttle, D. J., Abrahamson, M., Burnett, D., Mort, J. S., Barrett, A. J., Dando, P. M., & Hill, S. L. (1991). Human sputum cathepsin B degrades proteoglycan, is inhibited by a2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochemical Journal, 276(2), 325–331. doi:10.1042/bj2760325
   PubMedGoogle Scholar
• Buttle, D. J., Burnett, D., & Abrahamson, M. (1990). Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum, relationship to inflammation. Scandinavian Journal of Clinical and Laboratory Investigation, 50(5), 509–516.
   PubMed Web of Science ®Google Scholar
• Buttle, D. J., Burnett, D., & Abrahamson, M. (1990). Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: Relationship to inflammation. Scandinavian Journal of Clinical and Laboratory Investigation, 50(5), 509–516.
   PubMed Web of Science ®Google Scholar
• Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., … Sanchez, J. C. (2003). A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics, 3(8), 1486–1494. doi:10.1002/pmic.200300470
   PubMed Web of Science ®Google Scholar
• Cejka, J., & Fleischmann, L. E. (1973). Post- globulin: Isolation and physicochemical characterization. Archives of Biochemistry and Biophysics, 157(1), 168–176. doi:10.1016/0003-9861(73)90402-5
   PubMed Web of Science ®Google Scholar
• Chapman, H. A., Jr., Reilly, J. J., Jr., Yee, R., & Grubb, A. (1990). Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. The American Review of Respiratory Disease Returns, 141(3), 698–705. doi:10.1164/ajrccm/141.3.698
   PubMedGoogle Scholar
• Chaudhuri, A., Biswas, S., & Chakraborty, S. (2019). Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatin C coupled with pharmacophore elucidation. Journal of Biomolecular Structure and Dynamics, 37(2), 440–453. doi:10.1080/07391102.2018.1429311
   PubMed Web of Science ®Google Scholar
• Chen, J. M., Dando, P. M., Rawlings, N. D., Brown, M. A., Young, N. E., Stevens, R. A., … Barrett, A. J. (1997). Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. Journal of Biological Chemistry, 272(12), 8090–8098. doi:10.1074/jbc.272.12.8090
   PubMed Web of Science ®Google Scholar
• Chuo, L. J., Sheu, W. H., Pai, M. C., & Kuo, Y. M. (2007). Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Dementia and Geriatric Cognitive Disorders, 23(4), 251–257. doi:10.1159/000100021
   PubMed Web of Science ®Google Scholar
• Collins, A. R., & Grubb, A. (1991). Inhibitory effects of recombinant human cystatin C on human coronaviruses. Antimicrobial Agents Chemotherapy, 35(11), 2444–2446. doi:10.1128/AAC.35.11.2444
   PubMed Web of Science ®Google Scholar
• Commenges, D., Scotet, V., Renaud, S., Jacqmin-Gadda, H., Barberger-Gateau, P., & Dartigues, J. F. (2000). Intake of flavonoids and risk of dementia. European Journal of Epidemiology, 16(4), 357–363.
   PubMed Web of Science ®Google Scholar
• Crawford, F. C., Freeman, M. J., Schinka, J. A., Abdullah, L. I., Gold, M., Hartman, R., … Mullan, M. J. (2000). A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology, 55(6), 763–768. doi:10.1212/wnl.55.6.763
   PubMed Web of Science ®Google Scholar
• Cukor, D., Rosenthal, D. S., Jindal, R. M., Brown, C. D., & Kimmel, P. L. (2009). Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney International, 75(11), 1223–1229. doi:10.1038/ki.2009.51
   PubMed Web of Science ®Google Scholar
• Cygler, M., & Mort, J. S. (1997). Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity. Biochimie, 79(11), 645–652. doi:10.1016/S0300-9084(97)83497-9
   PubMed Web of Science ®Google Scholar
• Davies, M. E., & Barrett, A. J. (1984). Immunolocalization of human cystatins in neutrophils and lymphocytes. Histochemistry, 80(4), 373–377. doi:10.1007/BF00495420
   PubMedGoogle Scholar
• Delbridge, M. L., & Kelly, L. E. (1990, November 12). Sequence analysis, and chromosomal localization of a gene encoding a cystatin-like protein from Drosophila melanogaster. FEBS Lett, 274(1–2), 141–145.
   PubMed Web of Science ®Google Scholar
• Deng, A., Irizarry, M. C., Nitsch, R. M., Growdon, J. H., & Rebeck, G. W. (2001). Elevation of cystatin C in susceptible neurons in Alzheimer's disease. The American Journal of Pathology, 159(3), 1061–1068. doi:10.1016/S0002-9440(10)61781-6
   PubMed Web of Science ®Google Scholar
• Dice, J. F., Walker, C. D., Byrne, B., & Cardiel, A. (1978). General Characteristics of protein degradation in diabetes and starvation. Proceedings of the National Academy of Sciences of the United States of America, 75(5), 2093–2097.
   PubMed Web of Science ®Google Scholar
• Dieckmann, T., Mitschang, L., Hofmann, M., Kos, J., Turk, V., Auerswald, E. A., … Oschkinat, H. (1993). The structures of native phosphorylated chicken cystatin and of a recombinant unphosphorylated variant in solution. Journal of Molecular Biology, 234(4), 1048–1059.
   PubMed Web of Science ®Google Scholar
• Diop, N. N., Kidric, M., Repellin, A., Gareil, M., d'Arcy-Lameta, A., Pham, T. A. T., & Zuily-Fodil, Y. (2004). A multicystatin is induced by drought-stress in cowpea (Vigna unguiculata (L.) Walp.) leaves. FEBS Letters, 577(3), 545–550.
   PubMed Web of Science ®Google Scholar
• Drozak, J., & Bryła, J. (2005). [Dopamine: Not just a neurotransmitter]. Postepy Higieny i Medycyny Doswiadczalnej (Online)), 59, 405–420.
   PubMedGoogle Scholar
• Dubin, G. (2005). Proteinaceous cysteine protease inhibitors. Cellular and Molecular Life Sciences, 62(6), 653–669. doi:10.1007/s00018-004-4445-9
   PubMed Web of Science ®Google Scholar
• Eckert, A., Keil, U., Marques, C. A., Bonert, A., Frey, C., Schüssel, K., & Müller, W. E. (2003). Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochemical Pharmacology, 66(8), 1627–1634. Review.
   PubMed Web of Science ®Google Scholar
• Egede, L. E. (2007). Major depression in individuals with chronic medical disorders: Prevalence, correlates and association with health resource utilization, lost productivity and functional disability. General Hospital Psychiatry, 29(5), 409–416. doi:10.1016/j.genhosppsych.2007.06.002
   PubMed Web of Science ®Google Scholar
• Ekiel, I., Abrahamson, M., Fulton, D. B., Lindahl, P., Storer, A. C., Levadoux, W., … Gehring, K. (1997). NMR structural studies of human cystatin C dimers and monomers. Journal of Molecular Biology, 271(2), 266–277. doi:10.1006/jmbi.1997.1150
   PubMed Web of Science ®Google Scholar
• Elzanowski, A., Barker, W. C., Hunt, L. T., & Seibel-Ross, E. (1988). Cystatin domains in alpha-2-HS-glycoprotein and fetuin. FEBS Letters, 227(2), 167–170.
   PubMed Web of Science ®Google Scholar
• Eriksson, P., Deguchi, H., Samnegård, A., Lundman, P., Boquist, S., Tornvall, P., … Hamsten, A. (2004). Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(3), 551–557. doi:10.1161/01.ATV.0000117180.57731.36
   PubMed Web of Science ®Google Scholar
• Estrada, S., Nycander, M., Hill, N. J., Craven, C. J., Waltho, J. P., & Björk, I. (1998). The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L. Biochemistry, 37(20), 7551–7560.
   PubMed Web of Science ®Google Scholar
• Evans, H. J., & Barrett, A. J. (1987). A cystatin-like cysteine proteinase inhibitor from venom of the African puff adder (Bitis arietans). Biochemical Journal, 246(3), 795–797.
   PubMed Web of Science ®Google Scholar
• Filipek, R., Rzychon, M., Oleksy, A., Gruca, M., Dubin, A., Potempa, J., & Bochtler, M. (2003). The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. Journal of Biological Chemistry, 278(42), 40959–40966. Epub 2003 Jul 21.
   PubMed Web of Science ®Google Scholar
• Finkenstaedt, J. T. (1957). Intracellular distribution of proteolytic enzymes in rat liver tissue. Proceedings of the Society for Experimental Biology and Medicine, 95(2), 302–304. doi:10.3181/00379727-95-23201
   PubMed Web of Science ®Google Scholar
• Fossum, K., & Whitaker, J. R. (1968). Ficin and papain inhibitor from chicken egg white. Archives of Biochemistry and Biophysics, 125(1), 367–375.
   PubMed Web of Science ®Google Scholar
• Fräki, J. E. (1976). Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1. Archives of Dermatological Research, 255(3), 317–330.
   PubMed Web of Science ®Google Scholar
• Freije, J. P., Abrahamson, M., Olafsson, I., Velasco, G., Grubb, A., & López-Otín, C. (1991). Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. Journal of Biological Chemistry, 266(30), 20538–20543.
   PubMed Web of Science ®Google Scholar
• Fukuyama, K., Ohtani, O., Hibino, T., & Epstein, W. L. (1982). Cellular localization of thiol-proteinase inhibitor in the epidermis of the newborn rat. Cell and Tissue Research, 223(2), 313–323. doi:10.1007/BF01258492
   PubMed Web of Science ®Google Scholar
• Gabrijelcic, D., Annan-Prah, A., Rodic, B., Rozman, B., Cotic, V., & Turk, V. (1990). Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. Journal of Clinical Chemistry and Clinical Biochemistry, 28(3), 149–153.
   PubMedGoogle Scholar
• Galteau, M. M., Guyon, M., Gueguen, R., & Siest, G. (2001). Determination of serum cystatin C: Biological variation and reference values. Clinical Chemistry and Laboratory Medicine, 39, 850–857.
   PubMed Web of Science ®Google Scholar
• Gauthier, S., Kaur, G., Mi, W., Tizon, B., & Levy, E. (2011). Protective mechanisms by cystatin C in neurodegenerative diseases. Frontiers in Bioscience (Scholar Edition), 3, 541–554.
   PubMedGoogle Scholar
• Gauthier, S., Kaur, G., Mi, W., Tizon, B., & Levy, E. (2011). Protective mechanisms by cystatin C in neurodegenerative diseases. Frontiers in Bioscience (Bioscience), 3, 541–554. doi:10.2741/s170
   Google Scholar
• George, P. M., & Sheat, J. M. (1989). Cystatin C quantification in CSF. Clinical Chemistry, 35(1), 179–180.
   PubMed Web of Science ®Google Scholar
• Ghidoni, R., Benussi, L., Glionna, M., Desenzani, S., Albertini, V., Levy, E., … Binetti, G. (2010). Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. Journal of Alzheimer's Disease, 22(3), 985–991. doi:10.3233/JAD-2010-101095
   PubMed Web of Science ®Google Scholar
• Ghiso, J., Jensson, O., & Frangione, B. (1986). Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proceedings of the National Academy of Sciences of the United States of America, 33, 2974–2978. doi:10.1073/pnas.83.9.2974
   Google Scholar
• Green, G. D., Kembhavi, A. A., Davies, M. E., & Barrett, A. J. (1984). Cystatin-like cysteine proteinase inhibitors from human liver. Biochemical Journal, 218(3), 939–946. doi:10.1042/bj2180939
   PubMed Web of Science ®Google Scholar
• Grubb, A., Jensson, O., Gudmundsson, G., Arnason, A., Löfberg, H., & Malm, J. (1984). Abnormal metabolism of-/-trace alka-line microprotein. New England Journal of Medicine, 377, 1547–1549. doi:10.1056/NEJM198412133112406
   Google Scholar
• Gruzman, A., Wood, W. L., Alpert, E., Prasad, M. D., Miller, R. G., Rothstein, J. D., … Liu, J. (2007). Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 104(30), 12524–12529. doi:10.1073/pnas.0705044104
   PubMed Web of Science ®Google Scholar
• Guareschi, S., Cova, E., Cereda, C., Ceroni, M., Donetti, E., Bosco, D. A., … Pasinelli, P. (2012). An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proceedings of the National Academy of Sciences of the United States of America, 109(13), 5074–5079. doi:10.1073/pnas.1115402109
   PubMed Web of Science ®Google Scholar
• Halliday, G. M., Leverenz, J. B., Schneider, J. S., & Adler, C. H. (2014). The neurobiological basis of cognitive impairment in Parkinson's disease. Movement Disorders, 29(5), 634–650. doi:10.1002/mds.25857
   PubMed Web of Science ®Google Scholar
• Hamil, K. G., Liu, Q., Sivashanmugam, P., Yenugu, S., Soundararajan, R., Grossman, G., … Hall, S. H. (2002). Cystatin 11: A new member of the cystatin type 2 family. Endocrinology, 143(7), 2787–2796. doi:10.1210/endo.143.7.8925
   PubMed Web of Science ®Google Scholar
• Hansen, T., Petrow, P. K., Gaumann, A., Keyszer, G., Bräuer, R., & Kriegsmann, J. (2000). Synovial giant cells in rheumatoid arthritis: Expression of cystatin C, but not of cathepsin B. Exp Toxicol Pathol, 52(4), 312–316. doi:10.1016/S0940-2993(00)80055-X
   PubMedGoogle Scholar
• Hawley-Nelson, P., Roop, D. R., Cheng, C. K., Krieg, T. M., & Yuspa, S. H. (1988). Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Molecular Carcinogenesis, 7, 202–211. doi:10.1002/mc.2940010309
   Google Scholar
• Hedayati, S. S., Bosworth, H. B., Briley, L. P., Sloane, R. J., Pieper, C. F., Kimmel, P. L., & Szczech, L. A. (2008). Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney International, 74(7), 930–936. doi:10.1038/ki.2008.311
   PubMed Web of Science ®Google Scholar
• Hedayati, S. S., Bosworth, H. B., Kuchibhatla, M., Kimmel, P. L., & Szczech, L. A. (2006). The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International, 69(9), 1662–1668. doi:10.1038/sj.ki.5000308
   PubMed Web of Science ®Google Scholar
• Henskens, Y. M. C., Keijbus, P. A. M., Veerman, E. C. I., Weijden, G. A., Timmerman, M. F., Snoek, C. M., … Amerongen, A. (1996). Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. Journal of Periodontal Research, 31(1), 57–65. doi:10.1111/j.1600-0765.1996.tb00464.x
   PubMed Web of Science ®Google Scholar
• Henskens, Y. M. C., van der Weijden, F. A., van den Keijbus, P. A. M., Veerman, E. C. I., Timmerman, M. F., van der Veiden, U., & Amerongen, A. V. N. (1996). Effect of periodontal treatment on the protein composition of whole and parotid saliva. Journal of Periodontology, 67(3), 205–212. doi:10.1902/jop.1996.67.3.205
   PubMed Web of Science ®Google Scholar
• Henskens, Y. M. C., Veerman, E. C., & Nieuw Amerongen, A. V. (1996). Cystatins in health and disease. Biological Chemistry Hoppe-Seyler, 377(2), 71–86.
   PubMed Web of Science ®Google Scholar
• Henskens, Y. M. C., Veerman, E. C. I., Mantel, M. S., Van der Velden, U., & Nieuw Amerongen, A. V. (1994). Cystatins S and C in human whole saliva and glandular salivas in periodontal health and disease. Journal of Dental Research, 73(10), 1606–1614. doi:10.1177/00220345940730100501
   PubMed Web of Science ®Google Scholar
• Hibino, T., Fukuyama, K., & Epstein, W. L. (1980). Chemical characterization, synthesis and distribution of proteinase inhibitor in newborn rat epidermis. Biochimica et Biophysica Acta, 632(2), 214–226. doi:10.1016/0304-4165(80)90079-3
   PubMedGoogle Scholar
• Hill, A. J., Peikin, S. R., Ryan, C. A., & Blundell, J. E. (1990). Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiology & Behavior, 48(2), 241–246. doi:10.1016/0031-9384(90)90307-P
   PubMed Web of Science ®Google Scholar
• Hirado, M., Iwata, D., Niinobe, M., & Fujii, S. (1981). Purification and properties of thiol protease inhibitor from rat liver cytosol. Biochimica et Biophysica Acta, 669(1), 21–27. doi:10.1016/0005-2795(81)90218-X
   PubMedGoogle Scholar
• Hirado, M., Niinobe, M., & Fujuii, S. (1984). Purification and characterization of a bovine colostrum low molecular weight cysteine proteinase inhibitor. The Journal of Biochemistry, 96(1), 51–58. doi:10.1093/oxfordjournals.jbchem.a134828
   PubMed Web of Science ®Google Scholar
• Hirado, M., Tsunasawa, S., Sakiyama, F., Niinobe, M., & Fujii, S. (1985). Complete amino acid sequence of bovine colostrum low-Mr cysteine proteinase inhibitor. FEBS Letters, 186(1), 41–45. doi:10.1016/0014-5793(85)81335-1
   PubMed Web of Science ®Google Scholar
• Hochwald, G. M., & Thorbecke, G. J. (1962). Use of an antiserum against cerebrospinal fluid in demonstration of trace proteins in biological fluids. Proceedings of the Society for Experimental Biology and Medicine, 109(1), 91–95. doi:10.3181/00379727-109-27113
   PubMed Web of Science ®Google Scholar
• Hopsu-Havu, V., Järvinen, M., & Rinne, A. (1983). Separation of cysteine proteinase inhibitors from psoriatic scale. British Journal of Dermatology, 109, 77–85.
   PubMed Web of Science ®Google Scholar
• Hopsu-Havu, V. K., Järvinen, M., & Rinne, A. (1983). Separation of cysteine proteinase inhibitors from psoriatic scale. British Journal of Dermatology, 109(Suppl 25), 77–85.
   PubMedGoogle Scholar
• Hopsu-Havu, V. K., Joronen, I., Havu, S., Rinne, A., Järvinen, M., & Forsström, J. (1985). Serum cysteine proteinase inhibitors with special reference to kidney failure. Scandinavian Journal of Clinical and Laboratory Investigation, 45(1), 11–16. doi:10.3109/00365518509160966
   PubMed Web of Science ®Google Scholar
• Hopsu-Havu, V. K., Joronen, I. A., Järvinen, M. J., Rinne, A., & Aalto, M. (1984). Cysteine proteinase inhibitors produced by mononuclear phagocytes. Cell and Tissue Research, 236(1), 161–164. doi:10.1007/BF00216526
   PubMed Web of Science ®Google Scholar
• Hopsu-Havu, V. K., Joronen, I. A., Järvinen, M., & Rinne, A. (1983). Cysteine proteinase inhibitors in psoriatic epidermis. Archives of Dermatological Research, 275(5), 305–309. doi:10.1007/BF00417202
   PubMed Web of Science ®Google Scholar
• Hopsu-Havu, V. K., Kalimo, K., & Järvinen, M. (1981). Autoantibodies to an epidermal protease inhibitor in skin diseases. The British Journal of Dermatology, 104(6), 621–625.
   PubMed Web of Science ®Google Scholar
• Hua, Y., Zhao, H., Lu, X., Kong, Y., & Jin, H. (2012). Meta-analysis of the cystatin C(CST3) gene G73A polymorphism and susceptibility to Alzheimer's disease. International Journal of Neuroscience, 122(8), 431–438. doi:10.3109/00207454.2012.672502
   PubMed Web of Science ®Google Scholar
• Huang, W. C., Ploth, D. W., Bell, P. D., Work, J., & Navar, L. G. (1981). Bilateral renal function responses to converting enzyme inhibitor (SQ 20,881) in two-kidney, one clip Goldblatt hypertensive rats. Hypertension, 3(3), 285–293. doi:10.1161/01.HYP.3.3.285
   PubMed Web of Science ®Google Scholar
• Hunt, L. T., & Dayhoff, M. O. (1980). A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. Biochemical and Biophysical Research Communications, 95(2), 864–871. doi:10.1016/0006-291X(80)90867-0
   PubMed Web of Science ®Google Scholar
• Hunt, L. T., Barker, W. C., & Dayhoff, M. O. (1974). Epidermal growth factor: Internal duplication and probable relationship to pancreatic secretory trypsin inhibitor. Biochemical and Biophysical Research Communications, 60(3), 1020–1028. doi:10.1016/0006-291X(74)90415-X
   PubMed Web of Science ®Google Scholar
• Ibrahim, S., & El Salamony, O. (2008). Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. American Journal of Nephrology, 28(5), 784–791. doi:10.1159/000131101
   PubMed Web of Science ®Google Scholar
• Isemura, S., Saitoh, E., Ito, S., Isemura, M., & Sanada, K. (1984a). Cystatin S: A cysteine proteinase inhibitor of human saliva. The Journal of Biochemistry, 96(4), 1311–1314. doi:10.1093/oxfordjournals.jbchem.a134952
   PubMed Web of Science ®Google Scholar
• Isemura, S., Saitoh, E., Sanada, K., Isemura, M., & Ito, S. (1986). In V. Turk (Ed.). Cysteine proteinase and their inhibitors. Berlin: Water de Gruyter.
   Google Scholar
• Isemura, S., Saitoh, E., Sanada, K., & Minakata, K. (1991). Identification of full-sized forms of salivary (S-type) cystatins (cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of cystatin S) in human whole saliva and determination of phosphorylation sites of cystatin S. The Journal of Biochemistry, 110(4), 648–654. doi:10.1093/oxfordjournals.jbchem.a123634
   PubMed Web of Science ®Google Scholar
• Isemura, S., Saitoh, E., & Sanada, K. (1984b). Isolation and amino acid sequence of SAP-1, an acidic protein of human whole saliva, and sequence homology with human gamma-trace. The Journal of Biochemistry, 96(2), 489–498. doi:10.1093/oxfordjournals.jbchem.a134861
   PubMed Web of Science ®Google Scholar
• Jacobsson, B., Lignelid, H., & Bergerheim, U. S. (1995). Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology, 26(6), 559–564. doi:10.1111/j.1365-2559.1995.tb00275.x
   PubMed Web of Science ®Google Scholar
• Järvinen, M. (1976). Purification and properties of two protease inhibitors from rat skin inhibiting papain and other SH-proteases. Acta Chemica Scandinavica Series B: Organic Chemistry and Biochemistry, 30(10), 933–940.
   PubMedGoogle Scholar
• Järvinen, M. (1978). Purification and some characteristics of the human epidermal SH-protease inhibitor. The Journal of Investigative Dermatology, 71(2), 114–118.
   PubMed Web of Science ®Google Scholar
• Järvinen, M., & Rinne, A. (1982). Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants. Biochimica et Biophysica Acta, 708(2), 210–217. doi:10.1016/0167-4838(82)90222-9
   PubMedGoogle Scholar
• Järvinen, M., Pernu, H., Rinne, A., Hopsu-Havu, V. K., & Altonen, M. (1983). Localization of three inhibitors of cysteineproteinases in the human oral mucosa. Acta Histochemica, 73(2), 279–282. doi:10.1016/S0065-1281(83)80039-7
   PubMed Web of Science ®Google Scholar
• Järvinen, M., Rinne, A., & Hopsu-Havu, V. K. (1987). Human cystatins in normal and diseased tissues-A review. Acta Histochemica, 82(1), 5–18. doi:10.1016/S0065-1281(87)80043-0
   PubMed Web of Science ®Google Scholar
• Jenko Kokalj, S., Guncar, G., Stern, I., Morgan, G., Rabzelj, S., Kenig, M., … Turk, D. (2007). Essential role of proline isomerization in stefin B tetramer formation. Journal of Molecular Biology, 366(5), 1569–1579. doi:10.1016/j.jmb.2006.12.025
   PubMed Web of Science ®Google Scholar
• Jerala, R., Zerovnik, E., Kidric, J., & Turk, V. (1998). pH-induced conformational transitions of the propeptide of human cathepsin L. A role for a molten globule state in zymogen activation. Journal of Biological Chemistry, 273(19), 11498–11504. doi:10.1074/jbc.273.19.11498
   PubMed Web of Science ®Google Scholar
• Kabanda, A., Goffin, E., Bernard, A., Lauwerys, R., & van Ypersele de Strihou, C. (1995). Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney International, 48(6), 1946–1952. doi:10.1038/ki.1995.495
   PubMed Web of Science ®Google Scholar
• Kaeser, S. A., Herzig, M. C., Coomaraswamy, J., Kilger, E., Selenica, M. L., Winkler, D. T., … Jucker, M. (2007). Cystatin C modulates cerebral beta-amyloidosis. Nature Genetics, 39(12), 1437–1439. doi:10.1038/ng.2007.23
   PubMed Web of Science ®Google Scholar
• Kasprzykowski, F., Schalén, C., Kasprzykowska, R., Jastrzebska, B., & Grubb, A. (2000). Synthesis and antibacterial properties of peptidyl derivatives and cyclopeptides structurally based upon the inhibitory centre of human cystatin C. Dissociation of antiproteolytic and antibacterial effects. APMIS, 108(7–8), 473–481. doi:10.1034/j.1600-0463.2000.d01-85.x
   PubMed Web of Science ®Google Scholar
• Kastelic, L., Turk, B., Kopitar-Jerala, N., Stolfa, A., Rainer, S., Turk, V., & Lah, T. T. (1994). Stefin B, the major low molecular weight inhibitor in ovarian carcinoma. Cane Letters, 82(1), 81–88. doi:10.1016/0304-3835(94)90149-X
   PubMed Web of Science ®Google Scholar
• Kato, T., Heike, T., Okawa, K., Haruyama, M., Shiraishi, K., Yoshimoto, M., … Nakahata, T. (2006). A neurosphere-derived factor, cystatin C, supports differentiation of ES cells into neural stem cells. Proceedings of the National Academy of Sciences of the United States of America, 103(15), 6019–6024. doi:10.1073/pnas.0509789103
   PubMed Web of Science ®Google Scholar
• Katunuma, N., & Kominami, E. (1985). Molecular basis of intracellular regulation of thiol proteinase inhibitors. Current Topics in Cellular Regulation, 27, 345–360.
   PubMedGoogle Scholar
• Katunuma, N., Kominami, E., Hashida, S., & Wakamatsu, N. (1982). Modification of rat liver fructose biphosphate aldolase by lysosomal proteinases. Advances in Enzyme Regulation, 20, 337–350. doi:10.1016/0065-2571(82)90024-3
   PubMedGoogle Scholar
• Kaur, G., & Levy, E. (2012). Cystatin C in Alzheimer's disease. Frontiers in Molecular Neuroscience, 5(5), 79.doi:10.3389/fnmol.2012.00079
   PubMedGoogle Scholar
• Keilová, H., & Tomášek, V. (1975). Inhibition of cathepsin C by papain inhibitor from chicken egg white and by complex of this inhibitor with cathepsin B1. Collection of Czechoslovak Chemical Communications, 40(1), 218–224. doi:10.1135/cccc19750218
   Google Scholar
• Keilová, H., & Tomášek, V. (1977). Naturally occurring inhibitors of intracellular proteinases. Acta biologica et medica Germanica, 36(11–12), 1873–1881.
   PubMedGoogle Scholar
• Kennedy, D. O., & Haskell, C. F. (2011). Vitamins and cognition: What is the evidence? Drugs, 71(15), 1957–1971. doi:10.2165/11594130-000000000-00000
   PubMed Web of Science ®Google Scholar
• Khaki, P. S. S., Feroz, A., Amin, F., Rehman, M. T., Bhat, W. F., & Bano, B. (2017). Structural and functional studies on a variant of cystatin purified from brain of Capra hircus. Journal of Biomolecular Structure and Dynamics, 35(8), 1693–1709. doi:10.1080/07391102.2016.1191375
   PubMed Web of Science ®Google Scholar
• Khan, M. S., & Bano, B. (2009). Purification, characterization and kinetics of thiol protease inhibitor from goat (Capra hircus) lung. Biochemistry (Moscow)), 74(7), 781–788. doi:10.1134/S0006297909070116
   PubMed Web of Science ®Google Scholar
• Kirschke, H., Barrett, A. J., & Rawlings, N. D. (1995). Proteinases 1: Lysosomal cysteine proteinases. Protein Profile, 2(14), 1581–1643.
   PubMedGoogle Scholar
• Kitamura, N., Kitagawa, H., Fukushima, D., Takagaki, Y., Miyata, T., & Nakanishi, S. (1985). Structural organization of the human kininogen gene and a model for its evolution. The Journal of Biological Chemistry, 260(14), 8610–8617.
   PubMed Web of Science ®Google Scholar
• Knight, J. A. (1981). The liaison psychiatrist in kidney transplantation. International Journal of Psychiatry in Medicine, 10(3), 221–233.
   Web of Science ®Google Scholar
• Kominami, E., Wakamatsu, N., & Katunuma, N. (1982). Purification and characterization of thiol proteinase inhibitor from rat liver. Journal of Biological Chemistry, 257(24), 14648–14652.
   PubMed Web of Science ®Google Scholar
• Koo, J. R., Yoon, J. W., Kim, S. G., Lee, Y. K., Oh, K. H., Kim, G. H., … Son, B. K. (2003). Association of depression with malnutrition in chronic hemodialysis patients. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 41(5), 1037–1042.
   PubMed Web of Science ®Google Scholar
• Kopitar, M., Ritonja, A., Popovic, T., Gabrijelcic, D., Krizaj, I., & Turk, V. (1989). A new type of low-molecular mass cysteine proteinase inhibitor from pig leukocytes. Biological Chemistry Hoppe-Seyler, 370(10), 1145–1151.
   PubMed Web of Science ®Google Scholar
• Köppel, P., Baici, A., Keist, R., Matzku, S., & Keller, R. (1984). Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Experimental Cell Biology, 52(5), 293–299.
   PubMedGoogle Scholar
• Korant, B. D., Towatari, T., Ivanoff, L., Petteway, S., Brzin, J., Lenarcic, B., & Turk, V. (1986). Viral therapy: Prospects for protease inhibitors. Journal of Cellular Biochemistry, 32(2), 91–95. doi:10.1002/jcb.240320202
   PubMed Web of Science ®Google Scholar
• Korczyn, A. D., & Halperin, I. (2009). Depression and dementia. Journal of the Neurological Sciences, 283(1–2), 139–142. doi:10.1016/j.jns.2009.02.346
   PubMed Web of Science ®Google Scholar
• Kos, J., Stabuc, B., Schweiger, A., Krasovec, M., Cimerman, N., Kopitar-Jerala, N., & Vrhovec, I. (1997). Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clinical Cancer Research, 3(10), 1815–1822.
   PubMed Web of Science ®Google Scholar
• Koshizuka, Y., Yamada, T., Hoshi, K., Ogasawara, T., Chung, U. I., Kawano, H., … Kawaguchi, H. (2003). Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway. Journal of Biological Chemistry, 278(48), 48259–48266. doi:10.1074/jbc.M211639200
   PubMed Web of Science ®Google Scholar
• Kotsyfakis, M., Karim, S., Andersen, J. F., Mather, T. N., & Ribeiro, J. M. (2007). Selective cysteine protease inhibition contributes to blood-feeding success of the tick Ixodes scapularis. Journal of Biological Chemistry, 282(40), 29256–29263.
   PubMed Web of Science ®Google Scholar
• Krizaj, I., Turk, B., & Turk, V. (1992). The complete primary structure of bovine stefin B. FEBS Letters, 298(2–3), 237–239.
   PubMed Web of Science ®Google Scholar
• Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., … Zerr, I. (2005). “Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada”. Neurology, 64(9), 1586–1591. doi:10.1212/01.WNL.0000160117.56690.B2
   PubMed Web of Science ®Google Scholar
• Lah, T. T., Kokalj-Kunovar, M., Strukelj, B., Pungercar, J., Barlic-Maganja, D., Drobnic-Kosorok, M., … Turk, V. (1992a). Stefin and lysosomal cathepsins B, Land D in human breast carcinoma. International Journal of Cancer, 50(1), 36–44. doi:10.1002/ijc.2910500109
   PubMed Web of Science ®Google Scholar
• Lah, T. T., Clifford, J. L., Helmer, K. M., Day, N. A., Moin, K., Honn, K. V., … Sloane, B. F. (1989). Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochimica et Biophysica Acta, 993(1), 63–73. doi:10.1016/0304-4165(89)90144-X
   PubMedGoogle Scholar
• Lah, T. T., Kokalj-Kunovar, M., & Turk, V. (1990). Cysteine proteinase inhibitors in human cancerous tissues and fluids. Biological Chemistry Hoppe-Seyler, 371, 199–203.
   PubMed Web of Science ®Google Scholar
• Lah, T. T., Kokalj-Kunovar, M., Drobnic-Kosorok, M., Babnik, J., Golouh, R., Vrhovec, I., & Turk, V. (1992b). Cystatins and cathepsins in breast carcinoma. Biological Chemistry Hoppe-Seyler, 373(2), 595–604. doi:10.1515/bchm3.1992.373.2.595
   PubMedGoogle Scholar
• Laskowski, M., Jr., & Kato, I. (1980). Protein inhibitors of proteinases. Annual Review of Biochemistry, 49(1), 593–626.
   PubMedGoogle Scholar
• Lee, M. J., Yu, G. R., Park, S. H., Cho, B. H., Ahn, J. S., Park, H. J., … Kim, D. G. (2008). Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Clinical Cancer Research, 14(4), 1080–1089. doi:10.1158/1078-0432.CCR-07-1615
   PubMed Web of Science ®Google Scholar
• Lenarcic, B., Gabrijelcic, D., Rozman, B., Drobnic-Kosorok, M., & Turk, V. (1988a). Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biological Chemistry Hoppe-Seyler, 369, S257–S261.
   PubMed Web of Science ®Google Scholar
• Lenney, J. F., Tolan, J. R., Sugai, W. J., & Lee, A. G. (1979). Thermostable endogenous inhibitors of cathepsins B and H. European Journal of Biochemistry, 101(1), 153–161.
   PubMedGoogle Scholar
• Levy, E., Carman, M. D., & Fernandez-Madrid, I. J. (1990). Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage Dutch type. Science, 248, 1124–1126. doi:10.1126/science.2111584
   PubMed Web of Science ®Google Scholar
• Levy, E. (2008). Cystatin C: A potential target for Alzheimer's treatment. Expert Review of Neurotherapeutics, 8(5), 687–689. doi:10.1586/14737175.8.5.687
   PubMedGoogle Scholar
• Levy, E., Jaskolski, M., & Grubb, A. (2006). The role of cystatin C in cerebral amyloid angiopathy and stroke: Cell biology and animal models. Brain Pathology, 16(1), 60–70. doi:10.1111/j.1750-3639.2006.tb00562.x
   PubMed Web of Science ®Google Scholar
• Levy, E., Sastre, M., Kumar, A., Gallo, G., Piccardo, P., Ghetti, B., & Tagliavini, F. (2001). Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. Journal of Neuropathology and Experimental Neurology, 60(1), 94–104. doi:10.1093/jnen/60.1.94
   PubMed Web of Science ®Google Scholar
• Li, J. B., & Goldberg, A. L. (1976). Effects of food deprivation on protein synthesis and degradation in rat skeletal muscles. The American Journal of Physiology, 231(2), 441–448.
   PubMedGoogle Scholar
• Li, Y., Friel, P. J., Robinson, M. O., McLean, D. J., & Griswold, M. D. (2002). Identification and characterization of testis- and epididymis-specific genes: Cystatin SC and cystatin TE-11. Biology of Reproduction, 67(6), 1872–1880. doi:10.1095/biolreprod.102.003368
   PubMed Web of Science ®Google Scholar
• Lignelid, H., & Jacobsson, B. (1992). Cystatin C in the human pancreas and gut: An immunohistochemical study of normal and neoplastic tissues. Virchows Archive A Pathological Anatomy and Histopathology, 427, 491–495. doi:10.1007/BF01606878
   Google Scholar
• Löfberg, H., & Grubb, A. (1979). Quantification of gamma-trace in human biological fluids, indication for production in the central nervous system. Scandinavian Journal of Clinical and Laboratory Investigation, 39(7), 619–626. doi:10.3109/00365517909108866
   PubMed Web of Science ®Google Scholar
• Logroscino, G., Traynor, B. J., Hardiman, O., Chio', A., Couratier, P., Mitchell, J. D., … Beghi, E. (2008). Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues. Journal of Neurology, Neurosurgery, and Psychiatry, 79(1), 6–11. doi:10.1136/jnnp.2006.104828
   PubMed Web of Science ®Google Scholar
• Louwerse, E. S., Visser, C. E., Bossuyt, P. M., & Weverling, G. J. (1997). Amyotrophic lateral sclerosis: Mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. Journal of the Neurological Sciences, 152(Suppl 1), S10–S17. doi:10.1016/S0022-510X(97)00238-4
   PubMed Web of Science ®Google Scholar
• Lu, Y., Tang, C., Zhu, L., Li, J., Liang, H., Zhang, J., & Xu, R. (2016). The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A Transgenic mouse model of amyotrophic lateral sclerosis. International Journal of Biological Sciences, 12(9), 1140–1149. doi:10.7150/ijbs.15938
   PubMed Web of Science ®Google Scholar
• Luc, G., Bard, J.-M., Lesueur, C., Arveiler, D., Evans, A., Amouyel, P., … Ducimetiere, P. (2006). Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis, 185(2), 375–380. doi:10.1016/j.atherosclerosis.2005.06.017
   PubMed Web of Science ®Google Scholar
• Ludolph, A. C. (2011). Urgently needed-biomarkers for amyotrophic lateral sclerosis. Nature Reviews Neurology, 7(1), 13–14. doi:10.1038/nrneurol.2010.196
   PubMed Web of Science ®Google Scholar
• Machleidt, W., Borchart, U., Fritz, H., Brzin, J., Ritonja, A., & Turk, V. (1983). Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 364(2), 1481–1486. doi:10.1515/bchm2.1983.364.2.1481
   PubMedGoogle Scholar
• Manoury, B., Gregory, W. F., Maizels, R. M., & Watts, C. (2001). Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Current Biology, 11(6), 447–451. doi:10.1016/S0960-9822(01)00118-X
   PubMed Web of Science ®Google Scholar
• Martinez, M., Diaz-Mendoza, M., Carrillo, L., & Diaz, I. (2007). Carboxy terminal extended phytocystatins are bifunctional inhibitors of papain and legumain cysteine proteinases. FEBS Letters, 581(16), 2914–2918.
   PubMed Web of Science ®Google Scholar
• Mares, M., Meloun, B., Pavlik, M., Kostka, V., & Baudys, M. (1989). Primary structure of cathepsin D inhibitor from potatoes and its structure relationship to soybean trypsin inhibitor family. FEBS Letters, 251(1–2), 94–98. doi:10.1016/0014-5793(89)81435-8
   PubMed Web of Science ®Google Scholar
• Maruyama, H., Izumi, Y., Oda, M., Torii, T., Morino, H., Toji, H., … Kawakami, H. (2001). Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease. Neurology, 57(2), 337–339. doi:10.1212/WNL.57.2.337
   PubMed Web of Science ®Google Scholar
• Maruyama, K., Ikeda, S., Ishihara, T., Allsop, D., & Yanagisawa, N. (1990). Immuno-histochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C. Stroke, 21(3), 397–403. doi:10.1161/01.STR.21.3.397
   PubMed Web of Science ®Google Scholar
• Mathews, P. M., & Levy, E. (2016). Cystatin C in aging and in Alzheimer's disease. Ageing Research Reviews, 32, 38–50. doi:10.1016/j.arr.2016.06.003
   PubMed Web of Science ®Google Scholar
• McDonald, J. K., & Ellis, S. (1975). On the substrate specificity of cathepsins B1 and B2 including a new fluorogenic substrate for cathepsin B1. Life Sciences, 17(8), 1269–1276. doi:10.1016/0024-3205(75)90137-X
   PubMed Web of Science ®Google Scholar
• McGeer, P. L., & McGeer, E. G. (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research and Brain Research Reviews, 21(2), 195–218. doi:10.1016/0165-0173(95)00011-9
   PubMed Web of Science ®Google Scholar
• Mi, W., Pawlik, M., Sastre, M., Jung, S. S., Radvinsky, D. S., Klein, A. M., … Levy, E. (2007). Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nature Genetics, 39(12), 1440–1442. doi:10.1038/ng.2007.29
   PubMed Web of Science ®Google Scholar
• Miller, R. G., Mitchell, J. D., Lyon, M., & Moore, D. H. (2007). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews, CD001447.
   PubMed Web of Science ®Google Scholar
• Minakata, K., & Asano, M. (1985). Acidic cysteine proteinase inhibitor in seminal plasma. Biological Chemistry Hoppe-Seyler, 366(1), 15–18. doi:10.1515/bchm3.1985.366.1.15
   PubMed Web of Science ®Google Scholar
• Mirtti, T., Alanen, K., Kallajoki, M., Rinne, A., & Söderström, K. O. (2003). Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. The Prostate, 54(4), 290–298. doi:10.1002/pros.10196
   PubMed Web of Science ®Google Scholar
• Miyake, T., Gahara, Y., Nakayama, M., Yamada, H., Uwabe, K., & Kitamura, T. (1996). Upregulation of cystatin C by microglia in the rat facial nucleus following axotomy. Brain Research Molecular Brain Research, 37, 273–282.
   PubMedGoogle Scholar
• Molina, M. A., Marino, C., Oliva, B., Avilés, F. X., & Querol, E. (1994). C-tail valine is a key residue for stabilization of complex between potato inhibitor and carboxypeptidase A. The Journal of Biological Chemistry, 269(34), 21467–21472.
   PubMed Web of Science ®Google Scholar
• Möller, C. A., Löfberg, H., Grubb, A. O., Olsson, S. O., Davies, M. E., & Barrett, A. J. (1985). Distribution of cystatin C (gamma-trace), an inhibitor of lysosomal cysteine proteinases, in the anterior lobe of simian and human pituitary glands. Neuroendocrinology, 41(5), 400–404. doi:10.1159/000124209
   PubMed Web of Science ®Google Scholar
• Mussap, M., & Plebani, M. (2004). Biochemistry and clinical role of human cystatin C. Critical Reviews in Clinical Laboratory Sciences, 41(5–6), 467–550. doi:10.1080/10408360490504934
   PubMed Web of Science ®Google Scholar
• Mustafa, M. F., & Bano, B. (2014). Bilirubin binding with liver cystatin induced structural and functional changes. Journal of Fluorescence, 24(3), 967–974. doi:10.1007/s10895-014-1381-4
   PubMed Web of Science ®Google Scholar
• Nagai, A., Murakawa, Y., Terashima, M., Shimode, K., Umegae, N., Takeuchi, H., & Kobayashi, S. (2000). Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology, 55(12), 1828–1832. doi:10.1212/WNL.55.12.1828
   PubMed Web of Science ®Google Scholar
• Naito, Y., Sasaki, M., Umemoto, T., Namikawa, I., Sakae, K., Ishihara, Y., … Suzuki, I. (1995). Bactericidal effect of rat cystatin S on an oral bacterium Porphyromonas gingivalis. Comparative Biochemistry and Physiology Part C, Pharmacology Toxicology Endocrinology, 110(1), 71–75. doi:10.1016/0742-8413(94)00070-Q
   PubMed Web of Science ®Google Scholar
• Naito, Y., Suzuki, I., & Hasegawa, S. (1992). Induction of cystatin S in rat submandibular glands by papain. Comparative Biochemistry and Physiology, 102(4), 861–865.
   Google Scholar
• Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., … Nishimura, T. (1991). Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neuroscience Letters, 130(2), 195–198. doi:10.1016/0304-3940(91)90395-A
   PubMed Web of Science ®Google Scholar
• Ni, J., Abrahamson, M., Zhang, M., Fernandez, M. A., Grubb, A., Su, J., … Gentz, R. (1997). Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. Journal of Biological Chemistry, 272(16), 10853–10858.
   PubMed Web of Science ®Google Scholar
• Ni, J., Fernandez, M. A., Danielsson, L., Chillakuru, R. A., Zhang, J., Grubb, A., … Abrahamson, M. (1998). Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. Journal of Biological Chemistry, 273(38), 24797–24804.
   PubMed Web of Science ®Google Scholar
• Niemczyk, S., Piotrowska, M., & Szamotulska, K. (2012). [Usefulness of creatinine and cystatin C in the assessment of renal function in chronic kidney disease and coexisting diseases]. Polski Merkuriusz Lekarski, 32(191), 313–317.
   PubMedGoogle Scholar
• Nishida, Y., Sumi, H., & Mihara, H. (1984). A thiol protease inhibitor released from cultured human malignant melanoma cells. Cancer Research, 44(8), 3324–3329.
   PubMed Web of Science ®Google Scholar
• Nixon, R. A. (2000). A “protease activation cascade” in the pathogenesis of Alzheimer’s disease. Annals of the New York Academy of Sciences, 924, 117–131.
   PubMed Web of Science ®Google Scholar
• Noda, T., Isogai, K., Hayashi, H., & Katunuma, N. (1981). Susceptibilities of various myofibrillar proteins to cathepsin B and morphological alteration of isolated myofibrils by this enzyme. The Journal of Biochemistry, 90(2), 371–379. doi:10.1093/oxfordjournals.jbchem.a133483
   PubMed Web of Science ®Google Scholar
• North, M. J. (1982). Comparative biochemistry of the proteinases of eukaryotic microorganisms. Microbiological Reviews, 46(3), 308–340.
   PubMedGoogle Scholar
• Nycander, M., Estrada, S., Mort, J. S., Abrahamson, M., & Bjork, I. (1998). Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop. FEBS Letters, 422(1), 61–64. doi:10.1016/S0014-5793(97)01604-9
   PubMed Web of Science ®Google Scholar
• Ochieng, J., & Chaudhuri, G. (2010). Cystatin superfamily. Journal of Health Care for the Poor and Underserved, 21(1 Suppl), 51–70. doi:10.1353/hpu.0.0257
   PubMed Web of Science ®Google Scholar
• Okamoto, K., Hirai, S., Amari, M., Watanabe, M., & Sakurai, A. (1993). Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum. Neuroscience Letters, 162(1-2), 125–128. doi:10.1016/0304-3940(93)90576-7
   PubMed Web of Science ®Google Scholar
• Okamoto, K., Mizuno, Y., & Fujita, Y. (2008). Bunina bodies in amyotrophic lateral sclerosis. Neuropathology, 28(2), 109–115. doi:10.1111/j.1440-1789.2007.00873.x
   PubMed Web of Science ®Google Scholar
• Oliva, M. L., Carmona, A. K., Andrade, S. S., Cotrin, S. S., Soares-Costa, A., & Henrique-Silva, F. (2004). Inhibitory selectivity of canecystatin: a recombinant cysteine peptidase inhibitor from sugarcane. Biochemical and Biophysical Research Communications, 320(4), 1082–1086.
   PubMed Web of Science ®Google Scholar
• Palm, D. E., Knuckey, N. W., Primiano, M. J., Spangenberger, A. G., & Johanson, C. E. (1995). Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Research, 691(1–2), 1–8. doi:10.1016/0006-8993(95)00520-Z
   PubMed Web of Science ®Google Scholar
• Paraoan, L., & Grierson, I. (2007). Focus on molecules: Cystatin C. Experimental Eye Research, 84(6), 1019–1020. doi:10.1016/j.exer.2006.01.024
   PubMed Web of Science ®Google Scholar
• Pasinetti, G. M., Ungar, L. H., Lange, D. J., Yemul, S., Deng, H., Yuan, X., … Ho, L. (2006). Identification of potential CSF biomarkers in ALS. Neurology, 66(8), 1218–1222.
   PubMed Web of Science ®Google Scholar
• Paterson, D. S., Trachtenberg, F. L., Thompson, E. G., Belliveau, R. A., Beggs, A. H., Darnall, R., … Kinney, H. C. (2006). Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA, 296(17), 2124–2132.
   PubMed Web of Science ®Google Scholar
• Pelvig, D. P., Pakkenberg, H., Stark, A. K., & Pakkenberg, B. (2008). Neocortical glial cell numbers in human brains. Neurobiology of Aging, 29(11), 1754–1762. doi:10.1016/j.neurobiolaging.2007.04.013
   PubMed Web of Science ®Google Scholar
• Pennacchio, L. A., Lehesjoki, A. E., Stone, N. E., Willour, V. L., Virtaneva, K., Miao, J., … Myers, R. M. (1996). Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science, 271(5256), 1731–1734. doi:10.1126/science.271.5256.1731
   PubMed Web of Science ®Google Scholar
• Peralta, C. A., Shlipak, M. G., Fan, D., Ordoñez, J., Lash, J. P., Chertow, G. M., & Go, A. S. (2006). Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. Journal of the American Society of Nephrology, 17(10), 2892–2899. doi:10.1681/ASN.2005101122
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303–308. doi:10.1001/archneur.56.3.303
   PubMed Web of Science ®Google Scholar
• Pontremoli, S., Melloni, E., Salamino, F., Sparatore, B., Michetti, M., & Horecker, B. L. (1983). Endogenous inhibitors of lysosomal proteinases. Proceedings of the National Academy of Sciences of the United States of America, 80(5), 1261–1264.
   PubMed Web of Science ®Google Scholar
• Popović, T., Brzin, J., Ritonja, A., & Turk, V. (1990). Different forms of human cystatin C. Biological Chemistry Hoppe-Seyler, 371(7), 575–580.
   PubMed Web of Science ®Google Scholar
• Popovic, T., Cimerman, N., Dolenc, I., Ritonja, A., & Brzin, J. (1999). Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids. FEBS Letters, 455(1-2), 92–96.
   PubMed Web of Science ®Google Scholar
• Poulik, M. D., Shinnick, C. S., & Smithies, O. (1981). Partial amino acid sequences of human and dog post-gamma globulins. Molecular Immunology, 18(6), 569–572.
   PubMed Web of Science ®Google Scholar
• Priyadarshini, M., & Bano, B. (2010). Cystatin like thiol proteinase inhibitor from pancreas of Capra hircus: Purification and detailed biochemical characterization. Amino Acids, 38(4), 1001–1010. doi:10.1007/s00726-009-0308-x
   PubMed Web of Science ®Google Scholar
• Prusiner, S. B. (1998). “Prions”. Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13363–13383. doi:10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216(4542), 136–144.
   PubMed Web of Science ®Google Scholar
• Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D., Urbinelli, L., … Bowser, R. (2005). Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. Journal of Neurochemistry, 95(5), 1461–1471. doi:10.1111/j.1471-4159.2005.03478.x
   PubMed Web of Science ®Google Scholar
• Rashid, F., Sharma, S., Baig, M. A., & Bano, B. (2006). Molten globule state of human placental cystatin (HPC) at low pH conditions and the effects of trifluoroethanol (TFE) and methanol. Biochemistry and Cell Biology, 84(2), 126–134. doi:10.1139/o05-171">10.1139/o05-171
   PubMedGoogle Scholar
• Rawlings, N. D., & Barrett, A. J. (1990). Evolution of proteins of the cystatin superfamily. Journal of Molecular Evolution, 30(1), 60–71.
   PubMed Web of Science ®Google Scholar
• Rawlings, N. D., Tolle, D. P., & Barrett, A. J. (2004). Evolutionary families of peptidase inhibitors. Biochemical Journal, 378(3), 705–716. doi:10.1042/bj20031825
   PubMedGoogle Scholar
• Riccio, M., Di Giaimo, R., Pianetti, S., Palmieri, P. P., Melli, M., & Santi, S. (2001). Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Experimental Cell Research, 262(2), 84–94. doi:10.1006/excr.2000.5085
   PubMed Web of Science ®Google Scholar
• Rinne, A., Alavaikko, M., Järvinen, M., Martikainen, J., Karttunen, T., & Hopsu-Havu, V. (1983). Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymph node germinal centres. Virchows Archiv B Cell Pathology Including Molecular Pathology, 43(1), 121–126. doi:10.1007/BF02932949
   PubMedGoogle Scholar
• Rinne, A., Järvinen, M., Räsänen, O., & Dorn, A. (1980). [Demonstration of an epidermal SH-protease inhibitor in normal epithelium and in some human neoplasms—An immunological study (author's transl)]. Acta Histochemica, 22, 325–329.
   Google Scholar
• Rinne, A., Järvinen, M., & Räsänen, O. (1978). A protein reminiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat. Acta Histochemica, 63(2), 183–192. doi:10.1016/S0065-1281(78)80024-5
   PubMed Web of Science ®Google Scholar
• Rinne, A., Räsänen, O., Järvinen, M., Dammert, K., Kallioinen, M., & Hopsu-Havu, V. K. (1984). Occurrence of acid and neutrall cysteine proteinase inhibitors in epidermal malignancies: immunohistochemical study. Acta Histochemica, 74(1), 75–79.
   PubMed Web of Science ®Google Scholar
• Rohrlich, S. T., Levy, H., & Rifkin, D. B. (1985). Purification and characterization of a low molecular mass cysteine proteinase inhibitor from human amniotic fluid. Biological Chemistry Hoppe-Seyler, 366(1), 147–155. doi:10.1515/bchm3.1985.366.1.147
   PubMedGoogle Scholar
• Ryberg, H., An, J., Darko, S., Lustgarten, J. L., Jaffa, M., Gopalakrishnan, V., … Bowser, R. (2010). Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle & Nerve, 42(1), 104–111. doi:10.1002/mus.21683
   PubMed Web of Science ®Google Scholar
• Sadaf, Z., Shahid, P. B., & Bilqees, B. (2005). Isolation, characterization and kinetics of goat cystatins. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology, 142(4), 361–368. doi:10.1016/j.cbpb.2005.08.007
   PubMed Web of Science ®Google Scholar
• Salvesen, G., & Nagase, H. (1989). Inhibition of proteolytic enzymes. A practical approach. Practical approach series (vol. 5, pp. 83–104). Oxford: IRL Press.
   Google Scholar
• Sanchez, J. C., Guillaume, E., Lescuyer, P., Allard, L., Carrette, O., Scherl, A., … Hochstrasser, D. F. (2004). Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics, 4(8), 2229–2233. doi:10.1002/pmic.200300799
   PubMed Web of Science ®Google Scholar
• Sastre, M., Calero, M., Pawlik, M., Mathews, P. M., Kumar, A., Danilov, V., … Levy, E. (2004). Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiology of Aging, 25(8), 1033–1043. doi:10.1016/j.neurobiolaging.2003.11.006
   PubMed Web of Science ®Google Scholar
• Saxena, I., & Tayyab, S. (1997). Protein proteinase inhibitors from avian egg whites. Cellular and Molecular Life Sciences: CMLS, 53(1), 13–23.
   PubMed Web of Science ®Google Scholar
• Sekine, T., & Poulik, M. D. (1982). Post-gamma globulin: Tissue distribution and physicochemical characteristics of dog post-gamma globulin. Clinica Chimica Acta, 120(2), 225–235.
   PubMed Web of Science ®Google Scholar
• Sen, L. C., & Whitaker, J. R. (1973). Some properties of a ficin-papain inhibitor from avian egg white. Archives of Biochemistry and Biophysics, 158(2), 623–632.
   PubMed Web of Science ®Google Scholar
• Servais, A., Giral, P., Bernard, M., Bruckert, E., Deray, G., & Isnard Bagnis, C. (2008). Is serum cystatin-C a reliable marker for metabolic syndrome? The American Journal of Medicine, 121(5), 426–432. doi:10.1016/j.amjmed.2008.01.040
   PubMed Web of Science ®Google Scholar
• Shah, A., Priyadarshini, M., Khan, M. S., Aatif, M., Amin, F., & Bano, B. (2013). Biochemical, immunological and kinetic characterisation of thiol protease inhibitor (cystatin) from liver. Applied Biochemistry and Biotechnology, 171(3), 667–675. doi:10.1007/s12010-013-0383-z
   PubMed Web of Science ®Google Scholar
• Shamsi, A., Ahmed, A., & Bano, B. (2017). Biochemical, immunological and kinetic characterization and partial sequence analysis of a thiol proteinase inhibitor from Bubalus bubalis kidney: An attempt targeting kidney disorders. International Journal of Biological Macromolecules, 94(Pt B), 819–826. doi:10.1016/j.ijbiomac.2015.12.084
   PubMedGoogle Scholar
• Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., … Siscovick, D. S. (2006). Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Annals of Internal Medicine, 145(4), 237–246. doi:10.7326/0003-4819-145-4-200608150-00003
   PubMed Web of Science ®Google Scholar
• Siddiqui, M. F., & Bano, B. (2018). In-vitro assessment of the binding mechanism of oxyfluorfen (herbicide) with garlic phytocystatin: Multi-spectroscopic and isothermal titration calorimetric study. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2018.1544100
   Web of Science ®Google Scholar
• Siewiński, M. (1993). Autologous cysteine peptidase inhibitors as potential anticancer drugs. Anticancer Drugs, 4(1), 97–98. doi:10.1097/00001813-199302000-00013
   PubMed Web of Science ®Google Scholar
• Siklos, M., BenAissa, M., & Thatcher, G. R. (2015). Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharmaceutica Sinica B, 5(6), 506–519. doi:10.1016/j.apsb.2015.08.001
   PubMed Web of Science ®Google Scholar
• Simonsen, A. H., McGuire, J., Hansson, O., Zetterberg, H., Podust, V. N., Davies, H. A., … Blennow, K. (2007). Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Archives of Neurology, 64(3), 366–370. doi:10.1001/archneur.64.3.366
   PubMedGoogle Scholar
• Sloane, B. F., Moin, K., & Lah, T. T. (1994). In: TG Pretlow & TP Pretlow (Eds.), Biomedical and molecular aspects of selected cancers (pp. 411–472). New York: Academic Press.
   Google Scholar
• Sloane, B. F., & Honn, K. V. (1984). Cysteine proteinases and metastasis. Cancer Metastasis Reviews, 3(3), 249–263.
   PubMed Web of Science ®Google Scholar
• Söderström, K.-O., Laato, M., Wu, R., Hopsu-Havu, V. K., Nurmi, M., & Rinne, A. (1995). Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma. International Journal of Cancer, 62(1), 1–4. doi:10.1002/ijc.2910620102
   PubMed Web of Science ®Google Scholar
• Sohail, A., Bhat, S. A., Siddiqui, A. A., Zaman, M., Khan, R. H., & Bano, B. (2015). Conformational transitions induced by in vitro macromolecular crowding lead to the amyloidogenesis of buffalo heart cystatin. Journal of Molecular Recognition, 28(12), 699–709. doi:10.1002/jmr.2484
   PubMed Web of Science ®Google Scholar
• Sohar, I., Laszlo, A., Gaal, K., & Mechler, F. (1988). Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes. Biological Chemistry Hoppe-Seyler, 369(Suppl), 277–279.
   PubMedGoogle Scholar
• Solem, M., Rawson, C., Lindburg, K., & Barnes, D. (1990). Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochemical and Biophysical Research Communications, 172(2), 945–951. doi:10.1016/0006-291X(90)90767-H
   PubMed Web of Science ®Google Scholar
• Stenman, G., Aström, A.-K., Röijer, E., Sotiropoulou, G., Zhang, M., & Sager, R. (1997). Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics, 76(1–2), 45–46.
   PubMedGoogle Scholar
• Stennicke, H. R., & Salvesen, G. S. (2000). Caspases - controlling intracellular signals by protease zymogen activation. Biochimica et Biophysica Acta, 1477(1–2), 299–306. doi:10.1016/S0167-4838(99)00281-2
   PubMedGoogle Scholar
• Stoka, V., Turk, V., & Turk, B. (2016). Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Research Reviews, 32, 22–37. doi:10.1016/j.arr.2016.04.010Review.
   PubMed Web of Science ®Google Scholar
• Suhar, A., & Marks, N. (1979). Purification and properties of brain cathepsin B. Evidence for cleavage of pituitary lipotropins. European Journal of Biochemistry, 101(1), 23. doi:10.1111/j.1432-1033.1979.tb04211.x
   PubMedGoogle Scholar
• Sumbul, S., & Bano, B. (2006). Purification and characterization of high molecular mass and low molecular mass cystatin from goat brain. Neurochemical Research, 31(11), 1327–1336. doi:10.1007/s11064-006-9175-y
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, N., Wang, X., Liu, S., Chen, T., Zhang, L., … Cao, X. (2003). Molecular cloning and characterization of a novel cystatin-like molecule, CLM, from human bone marrow stromal cells. Biochemical and Biophysical Research Communications, 301(1), 176–182. doi:10.1016/S0006-291X(02)02985-6
   PubMed Web of Science ®Google Scholar
• Sun, Y., Chien, K. L., Hsu, H. C., Su, T. C., Chen, M. F., & Lee, Y. T. (2009). Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circulation Journal, 73(8), 1423–1430. doi:10.1253/circj.CJ-08-1077
   PubMed Web of Science ®Google Scholar
• Szadejko, K., Szabat, K., Ludwichowska, A., & Sławek, J. (2013). [Homocysteine and its role in pathogenesis of Parkinson's disease and other neurodegenerative disorders]. Przegla̧d Lekarski, 70(7), 443–447.
   PubMedGoogle Scholar
• Takahashi, M., Tezuka, T., & Katunuma, N. (1994). Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin alpha in skin cornified envelope. FEBS Letters, 355(3), 275–278. doi:10.1016/0014-5793(94)01196-6
   PubMed Web of Science ®Google Scholar
• Takahashi, M., Tezuka, T., & Katunuma, N. (1994). Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin in skin cornified envelope. FEBS Letters, 355(3), 275–278. doi:10.1016/0014-5793(94)01196-6
   PubMed Web of Science ®Google Scholar
• Testa, D., Lovati, R., Ferrarini, M., Salmoiraghi, F., & Filippini, G. (2004). Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5(4), 208–212. doi:10.1080/14660820410021311
   PubMed Web of Science ®Google Scholar
• Trabandt, A., Gay, R. E., Fassbender, H. G., & Gay, S. (2010). Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis & Rheumatology, 34(11), 1444–1451. doi:10.1002/art.1780341116
   Google Scholar
• Tsuji-Akimoto, S., Yabe, I., Niino, M., Kikuchi, S., & Sasaki, H. (2009). Cystatin C in cerebrospinal fluid as a biomarker of ALS. Neuroscience Letters, 452(1), 52–55. doi:10.1016/j.neulet.2009.01.026
   PubMed Web of Science ®Google Scholar
• Tsushima, H. (1993). Isolation of cysteine proteinase inhibitor, cystatin A, from human nails. Archives of Dermatological Research, 285(7), 418–422. doi:10.1007/BF00372136
   PubMed Web of Science ®Google Scholar
• Turk, B., Ritonja, A., Björk, I., Stoka, V., Dolenc, I., & Turk, V. (1995). Identification of bovine stefin A, a novel protein inhibitor of cysteine proteinases. FEBS Letters, 360(2), 101–105.
   PubMed Web of Science ®Google Scholar
• Turk, B., Dolenc, I., Lenarcic, B., Krizaj, I., Turk, V., Bieth, J. G., & Björk, I. (1999). Acidic pH as a physiological regulator of human cathepsin L activity. European Journal of Biochemistry, 259(3), 926–932.
   PubMedGoogle Scholar
• Turk, B., Krizaj, I., Kralj, B., Dolenc, I., Popovic, T., Bieth, J. G., & Turk, V. (1993). Bovine stefin C, a new member of the stefin family. The Journal of Biological Chemistry, 268(10), 7323–7329.
   PubMed Web of Science ®Google Scholar
• Turk, B., Stoka, V., & Rozman, J. (2001). International Symp. Proteinase Inhibitors. Biol. Control, Brdo, Slovenia, Book of Abstracts: 13.
   Google Scholar
• Turk, B., Turk, D., & Turk, V. (2000). Lysosomal cysteine proteases: More than scavengers. Biochimica et Biophysica Acta, 1477(1-2), 98–111. doi:10.1016/S0167-4838(99)00263-0
   PubMed Web of Science ®Google Scholar
• Turk, B., Turk, V., & Turk, D. (1997). Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biological Chemistry, 378(3–4), 141–150. Review.
   PubMed Web of Science ®Google Scholar
• Turk, V., & Bode, W. (1991). The cystatins: Protein inhibitors of cysteine proteinases. FEBS Letters, 285(2), 213–219. doi:10.1016/0014-5793(91)80804-C
   PubMed Web of Science ®Google Scholar
• Turk, V., Stoka, V., & Turk, D. (2008). Cystatins: Biochemical and structural properties, and medical relevance. Frontiers in Bioscience, 13, 5406–5420. doi:10.2741/3089
   PubMed Web of Science ®Google Scholar
• Turner, M. R., Kiernan, M. C., Leigh, P. N., & Talbot, K. (2009). Biomarkers in amyotrophic lateral sclerosis. The Lancet, Neurology, 8(1), 94–109. doi:10.1016/S1474-4422(08)70293-X
   PubMed Web of Science ®Google Scholar
• Unützer, J., Schoenbaum, M., Katon, W. J., Fan, M. Y., Pincus, H. A., Hogan, D., & Taylor, J. (2009). Healthcare costs associated with depression in medically Ill fee-for-service medicare participants. Journal of the American Geriatrics Society, 57(3), 506–510. doi:10.1111/j.1532-5415.2008.02134.x
   PubMed Web of Science ®Google Scholar
• Verdot, L., Lalmanach, G., Vercruysse, V., Hartmann, S., Lucius, R., Hoebeke, J., … Vray, B. (1996). Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. Journal of Biological Chemistry, 271(45), 28077–28081. doi:10.1074/jbc.271.45.28077
   PubMed Web of Science ®Google Scholar
• Vinters, H. V., Nishimura, G. S., Secor, D. L., & Pardridge, W. M. (1990). Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer’s disease. The American Journal of Pathology, 137, 233–240.
   PubMed Web of Science ®Google Scholar
• Wahlbom, M., Wang, X., Lindström, V., Carlemalm, E., Jaskolski, M., & Grubb, A. (2007). Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. Journal of Biological Chemistry, 282(25), 18318–18326. doi:10.1074/jbc.M611368200
   PubMed Web of Science ®Google Scholar
• Wang, Z. Z., Jensson, O., Thorsteinsson, L., & Vinters, H. V. (1997). Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS, 105(1–6), 41–47. doi:10.1111/j.1699-0463.1997.tb00538.x
   PubMed Web of Science ®Google Scholar
• Wasen, E., Isoaho, R., Mattila, K., Vahlberg, T., Kivela, S. L., & Irjala, K. (2004). Renal impairment associated with diabetes in the elderly. Diabetes Care, 27(11), 2648–2653. doi:10.2337/diacare.27.11.2648
   PubMed Web of Science ®Google Scholar
• Watanabe, S., Hayakawa, T., Wakasugi, K., & Yamanaka, K. (2014). Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death & Disease, 5, e1497. doi:10.1038/cddis.2014.459
   PubMed Web of Science ®Google Scholar
• Watnick, S., Kirwin, P., Mahnensmith, R., & Concato, J. (2003). The prevalence and treatment of depression among patients starting dialysis. American Journal of Kidney Diseases, 41(1), 105–110. doi:10.1053/ajkd.2003.50029
   PubMed Web of Science ®Google Scholar
• Weaver, T. R., Bergey, E. J., Levine, M. J., & Bobek, L. A. (1995). Effect of recombinant salivary cystatin on HSV-1 replication. Journal of Dental Research, 74, 84.
   Web of Science ®Google Scholar
• Wilson, M. E., Boumaza, I., Lacomis, D., & Bowser, R. (2010). Cystatin C: A candidate biomarker for amyotrophic lateral sclerosis. PLoS One, 5(12), e15133. doi:10.1371/journal.pone.0015133
   PubMed Web of Science ®Google Scholar
• Xiang, Y., Nie, D. S., Wang, J., Tan, X. J., Deng, Y., Luo, S. W., & Lu, G. X. (2005). Cloning, characterization and primary function study of a novel gene, Cymg1, related to family 2 cystatins. Acta Biochimica et Biophysica Sinica (Shanghai), 37(1), 11–18. doi:10.1093/abbs/37.1.11
   PubMed Web of Science ®Google Scholar
• Yaffe, K., Lindquist, K., Shlipak, M. G., Simonsick, E., Fried, L., Rosano, C., & … Kurella-Tamura, M. (2008). Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Annals of Neurology, 63(6), 798–802. doi:10.1002/ana.21383
   PubMed Web of Science ®Google Scholar
• Yajima, Y., & Kawashuma, S. (2001). Int. Symp. Proteinase Inhibitors Biol. Control, Brdo, Slovenia, Book of Abstracts: 32.
   Google Scholar
• Yamamoto-Watanabe, Y., Watanabe, M., Jackson, M., Akimoto, H., Sugimoto, K., Yasujima, M., … Shoji, M. (2010). Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3. Brain Research, 1361, 140–145. doi:10.1016/j.brainres.2010.09.033
   PubMed Web of Science ®Google Scholar
• Yang, Y., Liu, S., Qin, Z., Cui, Y., Qin, Y., & Bai, S. (2009). Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach. Molecular Biology Reports, 36(4), 677–682. doi:10.1007/s11033-008-9228-1
   PubMed Web of Science ®Google Scholar
• Yarnall, A. J., Rochester, L., & Burn, D. J. (2013). Mild cognitive impairment in Parkinson's disease. Age Ageing, 42(5), 567–576. doi:10.1093/ageing/aft085
   PubMed Web of Science ®Google Scholar
• Yasuhara, O., Hanai, K., Ohkubo, I., Sasaki, M., McGeer, P. L., & Kimura, H. (1993). Expression of cystatin C in rat, monkey and human brains. Brain Research, 628(1–2), 85–92.
   PubMed Web of Science ®Google Scholar
• Zabari, M., Berri, M., Rouchon, P., Zamora, F., Tassy, C., Ribadeau-Dumas, B., & Ouali, A. (1993). Purification and characterisation of a polymorphic low M(r) bovine muscle cysteine proteinase inhibitor: Structural identity with fatty-acid-binding proteins. Biochimie, 75(10), 937–945.
   PubMed Web of Science ®Google Scholar
• Zanusso, G., Monaco, S., Pocchiari, M., & Caughey, B. (2016). Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nature Reviews Neurology, 12(6), 325–333. doi:10.1038/nrneurol.2016.65 PMID:27174240
   PubMed Web of Science ®Google Scholar